BUENA, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback